NASDAQ: ILMN - Illumina

Yield per half year: -44.2%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Illumina

Extended chart Simple chart
Financial Markets by TradingView

About Illumina

Компания Illumina, Inc., основана в апреле 1998 года, занимается разработкой, производством и внедрением систем анализа генетического разнообразия и биологических функций. Illumina производит линейку продуктов и услуг для секвенирования, генотипирования и изучения экспрессии генов. 

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2000-07-28
ISIN US4523271090
Industry Life Sciences Tools & Services
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт http://www.illumina.com
Цена ао 81.57
Change price per day: 0% (81.57)
Change price per week: +9.45% (74.53)
Change price per month: +9.08% (74.78)
Change price per 3 month: -18.98% (100.68)
Change price per half year: -44.2% (146.17)
Change price per year: -29.43% (115.58)
Change price per 3 year: -65.29% (235)
Change price per 5 year: -78.34% (376.53)
Change price per 10 year: -50.99% (166.42)
Change price per year to date: -38.96% (133.63)
All parameters

Underestimation

Title Value Grade
P/S 4.86 3
P/BV 8.95 1
P/E 39.92 4
EV/EBITDA -31.36 0
Total: 3.25

Efficiency

Title Value Grade
ROA, % -14.9 0
ROE, % -30.13 0
Total: 0.3333

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 1.2

Debt

Title Value Grade
Debt/EBITDA -3.62 10
Total: 9.6

Growth impulse

Title Value Grade
Yield Revenue, % 34.94 5
Yield Ebitda, % -225 0
Yield EPS, % -273.63 0
Total: 1
More

Dividend, % Dividend Result of period Buy before Register closing date Payment before
3.81% 3.104 I кв. 2024 21.06.2024 25.06.2024 10.07.2024
More

Transaction date Date of disclosure Insider Type Price Volume Quantity Share before, % Share after, % Document
22.06.2023 26.06.2023 TOUSI SUSAN H
SVP, Chief Commercial Officer		 Sale 200 100 000 500 0 0 link
22.02.2023 23.02.2023 Aravanis Alexander
SVP, Chief Technology Officer		 Sale 201.74 1 088 990 5398 0 0 link
21.02.2023 23.02.2023 Aravanis Alexander
SVP, Chief Technology Officer		 Purchase 202.2 1 878 840 9292 0 0.01 link
28.03.2022 30.03.2022 Dadswell Charles
SVP & General Counsel		 Sale 342.83 126 161 368 0 0 link
30.08.2021 01.09.2021 TOUSI SUSAN H
SVP, Chief Commercial Officer		 Sale 463.5 139 050 300 0 0 link
22.04.2021 26.04.2021 Dadswell Charles
SVP & General Counsel		 Sale 402.02 126 234 314 0 0 link
15.12.2020 16.12.2020 FLATLEY JAY T
Director		 Sale 348.84 1 395 360 4000 0 0 link
14.12.2020 16.12.2020 Hoyt Aimee L
SVP, Chief People Officer		 Sale 345 122 130 354 0 0 link

Institutions Volume Share, %
Vanguard Group Inc 18178513 11.41
Blackrock Inc. 13302999 8.35
Edgewood Management Llc 6878495 4.32
State Street Corporation 6723616 4.22
Baillie Gifford and Company 5275769 3.31
Loomis Sayles & Company, LP 4424688 2.78
Janus Henderson Group PLC 4402380 2.76
Morgan Stanley 3698229 2.32
Geode Capital Management, LLC 3634176 2.28
Wellington Management Group, LLP 3239021 2.03

ETF Share, % Profitability for 1 year, % Dividends, %
Global X Telemedicine & Digital Health ETF Registered 4.01425 12.78 0.28226
Future Tech ETF 2.02764 426.34 0.8416
Principal Healthcare Innovators ETF 2.02764 618.5 0.8416
IQ Engender Equality ETF 1.49781 30.64 1.74017
Pacer BioThreat Strategy ETF 0.71622 14.04 1.65371
Syntax Stratified MidCap ETF 0.45703 17.66 1.56212
iShares Morningstar Mid-Cap Growth ETF 0.38685 9.66 0.94237
iShares Morningstar Mid-Cap ETF 0.19271 5.2 1.7458
Nationwide Nasdaq-100 Risk-Managed Income ETF 0.14325 21.38 0.87606
iShares Morningstar Large-Cap Growth ETF 0.08548 12.73 0.5823
iShares Morningstar Large-Cap ETF 0.04135 257.57 1.41244
JPMorgan U.S. Aggregate Bond ETF 0.03 2.4 1.33
Columbia U.S. ESG Equity Income ETF 0.02743 -99.18 1.44131



Head Job title Payment Year of birth
Stephanie Campos President N/A
Mr. Charles E. Dadswell Esq. Senior VP & General Counsel 1.06M 1959 (66 years)
Ms. Carissa L. Rollins Chief Information Officer N/A 1970 (55 years)
Dr. Steven Barnard Ph.D. Chief Technology Officer N/A
Ms. Sallilyn Schwartz Vice President of Investor Relations N/A
Mr. Jacob Thaysen Ph.D. CEO & Director N/A 1975 (50 years)
Mr. Ankur Dhingra Chief Financial Officer 1976 (49 years)
Mr. Kevin Carl Pegels Chief of Global Operations 1968 (57 years)
Mr. Scott Ericksen VP & Chief Accounting Officer 1973 (52 years)
Mr. Jakob Wedel Chief Strategy & Corporate Development Officer and CEO Chief of Staff

Address: United States, San Diego, 5200 Illumina Way - open in Google maps, open in Yandex maps
Website: http://www.illumina.com